FR2606018B1 - Nouveaux a-aminoacides substitues, leur preparation et leur utilisation en therapeutique comme medicaments - Google Patents

Nouveaux a-aminoacides substitues, leur preparation et leur utilisation en therapeutique comme medicaments

Info

Publication number
FR2606018B1
FR2606018B1 FR878714891A FR8714891A FR2606018B1 FR 2606018 B1 FR2606018 B1 FR 2606018B1 FR 878714891 A FR878714891 A FR 878714891A FR 8714891 A FR8714891 A FR 8714891A FR 2606018 B1 FR2606018 B1 FR 2606018B1
Authority
FR
France
Prior art keywords
aminoacids
therapeutics
drugs
preparation
novel substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR878714891A
Other languages
English (en)
Other versions
FR2606018A1 (fr
Inventor
Paul Linus Herrling
Werner Muller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2606018A1 publication Critical patent/FR2606018A1/fr
Application granted granted Critical
Publication of FR2606018B1 publication Critical patent/FR2606018B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3882—Arylalkanephosphonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR878714891A 1986-10-30 1987-10-26 Nouveaux a-aminoacides substitues, leur preparation et leur utilisation en therapeutique comme medicaments Expired - Lifetime FR2606018B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868625941A GB8625941D0 (en) 1986-10-30 1986-10-30 Substituted alpha-amino acids

Publications (2)

Publication Number Publication Date
FR2606018A1 FR2606018A1 (fr) 1988-05-06
FR2606018B1 true FR2606018B1 (fr) 1990-11-16

Family

ID=10606531

Family Applications (1)

Application Number Title Priority Date Filing Date
FR878714891A Expired - Lifetime FR2606018B1 (fr) 1986-10-30 1987-10-26 Nouveaux a-aminoacides substitues, leur preparation et leur utilisation en therapeutique comme medicaments

Country Status (27)

Country Link
US (1) US5162311A (fr)
JP (2) JPH0641475B2 (fr)
KR (1) KR950004960B1 (fr)
AT (1) AT393384B (fr)
AU (1) AU614726B2 (fr)
BE (1) BE1002421A4 (fr)
CA (1) CA1310331C (fr)
CH (1) CH677794A5 (fr)
CY (1) CY1703A (fr)
DE (1) DE3736016C2 (fr)
DK (1) DK565987A (fr)
ES (1) ES2012521A6 (fr)
FI (1) FI87222C (fr)
FR (1) FR2606018B1 (fr)
GB (2) GB8625941D0 (fr)
GR (1) GR871659B (fr)
HK (1) HK110393A (fr)
HU (1) HU200465B (fr)
IE (1) IE59310B1 (fr)
IL (1) IL84302A (fr)
IT (1) IT1212033B (fr)
LU (1) LU87031A1 (fr)
NL (1) NL8702485A (fr)
NZ (1) NZ222333A (fr)
PT (1) PT86018B (fr)
SE (1) SE466311B (fr)
ZA (1) ZA878176B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395827A (en) * 1986-04-09 1995-03-07 Guilford Pharmaceuticals Inc. ω-[2-(phosphonoalkyl)phenyl]-2-aminoalkanoic acids as antagonists of excitatory amino acid receptors
US4918064A (en) * 1987-10-21 1990-04-17 G. D. Searle & Co. Phenyl glycines for use in reducing neurotoxic injury
US5175153A (en) * 1987-11-30 1992-12-29 Warner-Lambert Company Substituted alpha-amino acids having pharmaceutical activity
FR2634763B1 (fr) * 1988-08-01 1991-07-12 Inst Nat Sante Rech Med Amino-acides et peptides presentant un residu tyrosine modifiee, leur preparation et leur application comme medicaments
US5177240A (en) * 1988-10-21 1993-01-05 G. D. Searle & Co. O-phosphono(alkyl)-n-sulfonyl-phenyl-alanine derivatives useful as intermediates for preparation of phosphono-hydroisoquinolines
US4997821A (en) * 1988-10-21 1991-03-05 Cordi Alexis A Phosphono-hydroisoquinoline compounds useful in reducing neurotoxic injury
US5100654A (en) * 1989-04-07 1992-03-31 Yale University Phosphorylated derivatives of l-dopa and compositions and methods for increasing the melanin content in mammalian skin and hair
DE3940410A1 (de) * 1989-12-04 1991-06-06 Schering Ag Neue verwendung von nmda-rezeptor-antagonisten
US5238958A (en) * 1990-02-26 1993-08-24 Warner-Lambert Company Substituted α-amino acids having selected acidic moieties for use as excitatory amino acid antagonists in pharmaceuticals
US5086072A (en) * 1990-06-18 1992-02-04 The United States Of America As Represented By The Department Of Health And Human Services Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex
US5264607A (en) * 1991-09-30 1993-11-23 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Process of making benzylic α,α-diflurophosphonates from benzylic α-ketophosphorates
US5200546A (en) * 1991-09-30 1993-04-06 The United States Of America As Represented By The Department Of Health And Human Services Phosphonoalkyl phenylalanine compounds suitably protected for use in peptide synthesis
US5475129A (en) * 1991-09-30 1995-12-12 The United States Of America As Represented By The Department Of Health And Human Services Phosphonoalkyl phenylalanine compounds suitably protected for use in peptide synthesis
GB9325360D0 (en) * 1993-12-10 1994-02-16 Univ Bristol Organic compounds
US5489717A (en) * 1994-07-08 1996-02-06 Warner-Lambert Company Glutamate (NMDA) receptor antagonists
GB9423019D0 (en) * 1994-11-15 1995-01-04 Sandoz Ltd Improvements in or relating to organic compounds
US5922697A (en) * 1996-10-02 1999-07-13 Warner-Lambert Company Compounds, compositions and methods for inhibiting the binding of proteins containing an SH2 domain to cognate phosphorylated proteins
US6133281A (en) * 1996-10-24 2000-10-17 Harbor-Ucla Research And Education Institute NMDA receptor blockers in the therapy of urogenital disease
EP2246058A1 (fr) * 1997-09-04 2010-11-03 Novoneuron, Inc. Noribogain utilisée pour le traitement de la douleur et de la toxicomanie
MY153569A (en) * 1998-01-20 2015-02-27 Mitsubishi Tanabe Pharma Corp Inhibitors of ?4 mediated cell adhesion
SE9804064D0 (sv) 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
MY140707A (en) * 2002-02-28 2010-01-15 Mitsubishi Tanabe Pharma Corp Process for preparing a phenylalanine derivative and intermediates thereof
DE10328260A1 (de) * 2003-06-23 2005-01-27 Schmidt, K.-G., Dr. med. Flupirtine-Präparat
EP1754483A1 (fr) * 2005-08-18 2007-02-21 Merck Sante Utilisation des dérivés de thiénopyridone comme activateurs de l'AMPK et compositions pharmaceutiques les contenant
WO2011154705A1 (fr) 2010-06-09 2011-12-15 Queen Mary & Westfield College Anticorps anti-annexine 1
GB201121564D0 (en) * 2011-12-14 2012-01-25 Queen Mary & Westfield College Use of antibody
GB201702091D0 (en) 2017-02-08 2017-03-22 Medannex Ltd Specific binding molecules
EP3427729A1 (fr) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probénécide destiné à être utilisé dans le traitement de maladies, troubles ou états épileptiques

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550634A (fr) * 1955-08-30
NL137849C (fr) * 1961-12-30
DE2459491A1 (de) * 1974-12-17 1976-06-24 Bayer Ag Gegenueber isocyanaten reaktive phosphorhaltige flammschutzmittel
US4657899A (en) * 1986-04-09 1987-04-14 Nova Pharmaceutical Corporation Antagonists of specific excitatory amino acid neurotransmitter receptors
US4761405A (en) * 1987-03-04 1988-08-02 Nova Pharmaceutical Corporation Antagonists of specific excitatory amino acid neurotransmitter receptors having increased potency
US4918064A (en) * 1987-10-21 1990-04-17 G. D. Searle & Co. Phenyl glycines for use in reducing neurotoxic injury

Also Published As

Publication number Publication date
IE59310B1 (en) 1994-02-09
FI87222C (fi) 1992-12-10
GB2198134A (en) 1988-06-08
GR871659B (en) 1988-03-03
SE8704204D0 (sv) 1987-10-28
SE466311B (sv) 1992-01-27
IT1212033B (it) 1989-11-08
DK565987D0 (da) 1987-10-28
PT86018A (en) 1987-11-01
ATA285187A (de) 1991-03-15
AT393384B (de) 1991-10-10
CH677794A5 (fr) 1991-06-28
FI874761A (fi) 1988-05-01
IL84302A0 (en) 1988-03-31
US5162311A (en) 1992-11-10
PT86018B (pt) 1990-07-31
CA1310331C (fr) 1992-11-17
SE8704204L (sv) 1988-05-01
IT8748544A0 (it) 1987-10-28
HUT47949A (en) 1989-04-28
IL84302A (en) 1993-06-10
DK565987A (da) 1988-05-01
NL8702485A (nl) 1988-05-16
HK110393A (en) 1993-10-29
JPS63122693A (ja) 1988-05-26
AU614726B2 (en) 1991-09-12
NZ222333A (en) 1990-09-26
KR950004960B1 (ko) 1995-05-16
GB8724186D0 (en) 1987-11-18
IE872908L (en) 1988-04-30
ES2012521A6 (es) 1990-04-01
BE1002421A4 (fr) 1991-02-05
CY1703A (en) 1994-01-14
FI874761A0 (fi) 1987-10-29
ZA878176B (en) 1989-06-28
GB2198134B (en) 1990-07-04
FI87222B (fi) 1992-08-31
HU200465B (en) 1990-06-28
FR2606018A1 (fr) 1988-05-06
AU8040487A (en) 1988-05-05
DE3736016C2 (de) 1995-04-20
JPH0641475B2 (ja) 1994-06-01
DE3736016A1 (de) 1988-05-05
LU87031A1 (fr) 1988-05-03
KR890006661A (ko) 1989-06-15
GB8625941D0 (en) 1986-12-03
JPH03101685A (ja) 1991-04-26

Similar Documents

Publication Publication Date Title
FR2606018B1 (fr) Nouveaux a-aminoacides substitues, leur preparation et leur utilisation en therapeutique comme medicaments
FR2531083B1 (fr) Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
FR2615191B1 (fr) Nouveaux benzo(b)pyrannes et pyrannopyridines, leur preparation et leur utilisation comme medicaments
FR2620451B1 (fr) Nouveaux inhibiteurs de la renine, leur preparation et leur utilisation comme medicaments
FR2629825B1 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments
FR2551064B1 (fr) Nouveaux esters et amides aromatiques, leur preparation et leur utilisation comme medicaments
FR2590902B1 (fr) Nouveaux derives de la calcitonine, leur preparation et leur utilisation comme medicaments
FR2561651B1 (fr) Nouveaux derives de la cyclosporine, leur preparation et leur utilisation comme medicaments
FR2501199B1 (fr) Nouveaux polypeptides, leur preparation et leur application comme medicaments
FR2607507B1 (fr) Nouveaux derives a-d-oligonucleotides, leur preparation et leur emploi
FR2606410B1 (fr) Imidazopyridines, leur preparation et leur application en therapeutique
FR2607505B1 (fr) Nouveaux derives de piperazinyl-1 pyrimidine, leur preparation et leur application en therapeutique et cosmetique
FR2617171B1 (fr) Nouveaux derives de la somatostatine, leur preparation et leur utilisation comme medicaments
FR2531962B1 (fr) Nouveaux derives de la desoxyuridine, leur preparation et leur utilisation comme medicaments
FR2511378B1 (fr) Nouveaux aminoacides isomeres, leur preparation et leur application en medecine
FR2560196B1 (fr) Nouvelles 8a-acylaminoergolines, leur preparation et leur utilisation comme medicaments
BE896590A (fr) Nouveaux azepino-indoles leur preparation et leur utilisation comme medicaments
FR2640271B1 (fr) Nouveaux derives de l'adenosine, leur preparation et leur utilisation comme medicaments
FR2596051B1 (fr) Nouveaux derives de la purine, leur preparation et leur utilisation comme medicaments
BE887474A (fr) Nouveaux thioloesters, leur preparation et leur utilisation en synthese
BE874683A (fr) Nouveaux derives bicyclo-octaniques leur preparation et leur utilisation comme medicaments
ZA872739B (en) Benzimidazolesulfonamides and imidazopyridine-sulfonamides,their preparation and their application as drugs
FR2528431B1 (fr) Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments
FR2532308B1 (fr) Nouveaux polypeptides, leur preparation et leur application comme medicaments
FR2536072B1 (fr) Nouveaux derives de la quinazoline, leur preparation et leur utilisation comme medicaments

Legal Events

Date Code Title Description
ER Errata listed in the french official journal (bopi)

Free format text: 18/88

TP Transmission of property
ST Notification of lapse